In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Zimmer Biomet's current price at $108.33 is substantially below its PERT-weighted fair value of $220.82, indicating potential undervaluation with a high confidence level. Monte Carlo analysis shows significant upside and low downside risk, though financial health scores reveal fair profitability and growth with high leverage. Valuation methods vary widely, reflecting diverse market perspectives and inherent volatility.